About This Webinar
The genetic test industry continues to grow at a rapid rate with 10+ new genetic tests hitting the market each day. At the same time, the number of CPT codes identifying these tests is not at a 1:1 ratio, and the number of individuals qualified to interpret the quality of these tests is limited. This lack of genetic test specificity coupled with the variability in the quality and utility of precision medicine tests, creates challenges for health plans throughout the adjudication process.
Join Optum and Palmetto experts as they walk through a clinical scenario highlighting the complexities of genetic testing management and learn how DEX Z-Codes® empower health plans with discrete test identification and quality insights to drive transparency throughout the claims process.
In this session, attendees will learn how they can better manage genetic testing lab benefits and drive quality tests by adopting DEX Z-Codes®.
Attendees Will Learn About
- The challenges health insurance providers face when genetic tests are not identified at the discreet test level
- How DEX Z-Codes® are not just an “administrative identifier,” and how they are a commitment to establishing base test quality through a multifaceted and expert driven process
- How the adoption of DEX Z-Codes® enables quality and price transparency throughout the adjudication process creating less administrative burden
